• No results found

University of Groningen Immunity to varicella-zoster virus in immunocompromised patients Rondaan, Christien

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Immunity to varicella-zoster virus in immunocompromised patients Rondaan, Christien"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Immunity to varicella-zoster virus in immunocompromised patients

Rondaan, Christien

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Rondaan, C. (2018). Immunity to varicella-zoster virus in immunocompromised patients. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Immunity to varicella-zoster virus in

immunocompromised patients

(3)

© Christien Rondaan, Groningen, 2018.

All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, without permission of the author.

The research presented in this thesis was financially supported by the Reumafonds/Dutch Arthritis Association (NC Smit Fonds), a Healthy Ageing grant from the University Medical Center Groningen, the Jan Kornelis de Cock stichting, and an unrestricted grant from Merck Sharp & Dohme.

The printing of this thesis was financially supported by the Graduate School of Medical Sciences of the University Medical Center Groningen, University of Groningen and ChipSoft.

(4)

Immunity to varicella-zoster virus in

immunocompromised patients

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op maandag 19 maart 2018 om 14.30 uur

door

Christien Rondaan geboren op 2 mei 1991

(5)

Dr. S. van Assen

Beoordelingscommissie

Prof. dr. S.J.L. Bakker

Prof. dr. A.L.W. Huckriede Prof. dr. N.M. Wulffraat

(6)

TABLE OF CONTENTS

Chapter 1 Introduction 7 Part I Immunity to varicella-zoster virus in immunocompromised 27

patient groups

Chapter 2 Altered cellular and humoral immunity to varicella-zoster virus 29 in patients with autoimmune diseases

Arthritis & Rheumatology 2014;66:3122-8.

Chapter 3 Longitudinal analysis of varicella-zoster virus specific antibodies in 43 Systemic Lupus Erythematosus: No association with subclinical viral

reactivations or lupus disease activity Submitted

Chapter 4 Decreased immunity to varicella-zoster virus in giant cell arteritis 61 Frontiers in Immunology 2017;8:1377

Chapter 5 Increased incidence of herpes zoster in patients on renal replacement 79 therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus

Submitted

Chapter 6 Immune response to varicella-zoster virus before and after 95 renal transplantation

Submitted

Part II Vaccination of patients with autoimmune inflammatory 117 rheumatic diseases

Chapter 7 Vaccination of patients with autoimmune inflammatory 119 rheumatic diseases

Nature Reviews Rheumatology 2015;11:135-45

Chapter 8 Proposal for updated recommendations for vaccination in 149 adult patients with autoimmune inflammatory rheumatic diseases

Manuscipt in preparation

Chapter 9 Summary, discussion and future perspectives 183 Chapter 10 Nederlandse samenvatting 201 Dankwoord 208

(7)

Referenties

GERELATEERDE DOCUMENTEN

Patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) are at high risk for developing herpes zoster.. Herpes zoster is a disease which is characterized by

Frequencies of cytokine-producing CD4+ T cells upon stimulation with varicella- zoster virus (VZV) (A-B-C) and staphylococcal enterotoxin B (SEB, positive control) (D-E-F) in

Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster

In a prospective pilot study of 10 patients with SLE and 10 healthy individuals, excluding patients with an SLE disease activity index (SLEDAI) score >4 and those treated

High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Shinjo SK,

Vaccination using a live attenuated zoster vaccine has been shown to reduce the risk of herpes zoster by half in renal dialysis patients, with a risk of 11.7 per 1000 person-

Omdat zowel humorale als cellulaire afweer tegen varicella-zoster virus niet significant verschilden tussen de groep dialysepatiënten en de gezonde controlegroep, kunnen we het

De complicaties rejectie en infectie anders dan gordelroos, gaan samen met een lagere cellulaire afweer tegen het varicella-zoster virus bij niertransplantatiepatiënten. Het